Antitumor activity of glycosylated molluscan hemocyanins via Guerin ascites tumor

Immunological Investigations

Volumn 40, Issue 2, 2011, Pages 130-149

  Dolashka, Pavlina ^a   Velkova, Ludmyla ^a   Iliev, Ilyan ^b   Beck, Alexander ^c   Dolashki, Alexander ^c   Yossifova, Liliya ^b   Toshkova, Reneta ^b   Voelter, Wolfgang ^c   Zacharieva, Sya ^b  

^a INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^b BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

GAT; Helix lucorum; Hemocyanin; Rapana venosa

Indexed keywords

HELIX VULGARIS HEMOCYANIN; HEMOCYANIN; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; RAPANA VENOSA HEMOCYANIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASCITES TUMOR; CANCER SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GUERIN TUMOR; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME;

EID: 78650960236     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2010.513408     Document Type: Article

References (49)

1. Arcangeli, A., Lucio Toma, L., Contiero, L., Crociani, O.. Legnani, L., Lungh, C., Nesti, E., Moneti, G., Richich B., Nativi, C. (2010). Stable GM3 lactone mimetic raises antibodies specific for the antigens expressed on melanoma cells. Bioconj. Chem. 29(8):1432-1438.
2. Beck, A., Hillen, N., Dolashki, A., Stevanovic, S., Salvato, B., Voelter, W., Dolashka-Angelova, P. (2007). Oligosaccharide structure of a functional unit RvH1-b of Rapana venosa hemocyanin using HPLC/electrospray ionization mass spectrometry. Biochimie 89(8):938-949.
3. Benjamin, D. C., Berzofsky, J. A., East, I.J. (1984). The antigenic structure of proteins: a reappraisal. Annu. Rev. Immunol. 2:67-101.
4. Bonaventura, J., Bonaventura, C. (1980). Hemocyanins relationships in their structure, function and assembly. Amer. Zool., 20(1):7-17.
5. Carr, S. A., Huddleston, M. J., Bean, M. F. (1993). Selective identification and differentiation of N-and O-linked oligosaccharides in glycoproteins by liquid chromatography-mass spectrometry. Protein Sci. 2:183-196.
6. Chiarella, P., Edelmann, B., Fazio, V. M., Sawyer, A. M., de Marco, A. (2010). Antigenic features of protein carriers commonly used in immunisation trials. Biotechnol. Lett. 32(9):1215-1221.
7. Celluzzi, C. M., Mayordomo, I. J., Storkus, J. W., Lotze, T. M., Falo, D. L. (1996). Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283-287.
8. Dolashka-Angelova, P., Beck, A.; Dolashki, A., Beltramini, M., Stevanovic, S., Salvato, B., Hristova, R., Velkova, L., Voelter, W. (2004). Carbohydrate moieties of molluscan Rapana venosa hemocyanin. Micron 35:101-104.
9. Dolashka-Angelova, P., Lieb, B.; Velkova, L., Heilen, N., Sandra, K., Nikolaeva-Glomb, L., Dolashki, A., Galabov, A. S., Beeumen, J. V., Stevanovic, S., Voelter, W., Devreese, B. (2009). Identification of glycosylated sites in Rapana hemocyanin by mass spectrometry and gene sequence, and their antiviral effect. Bioconjug Chem. 20(7):1315-1322.
10. Dolashka-Angelova, P., Schwarz, H., Dolashki, A., Beltramini, M., Salvato, B., Schick, M., Saeed, M., Voelter, W. (2003). Oligomeric stability of Rapana venosa hemocyanin (RvH) and its structural subunits. Biochim. Biophys. Acta 1646(1-2):77-85.
11. Dolashka-Angelova, P., Stefanova, T., Livaniou, E., Velkova, L., Klimentzou, P., Stevanovic, S., Neychev, H., Schwarz, H., Voelter, W. (2008). Immunological potential of Helix vulgaris and Rapana venosa hemocyanins. Immunol. Invest. 37(8): 822-40.
12. Donald, L., Jean, I., Dehaven, R., Riggs, D. (2000). Keyhole limpet hemocyanin immunotherapy of bladder cancer: Laboratory and clinical studies. Eur. Urol. (37):41-44.
13. Gielens, C., De Geest, N., Compernolle, F., Préaux, G. (2004). Glycosylation sites of hemocyanins of Helix pomatia and Sepia officinalis. Micron 35:99-100.
14. Harris, J. R., Markl, J. (1999). Keyhole limpet hemocyanin (KLH): A biomedical review. Micron 30(6):597-623.
15. Harris, R. J., Markl, J. (2000). Keyhole limpet hemocyanin: Molecular structure of a potent marine immunoactivator. Eur. Urol. 37:24-33.
16. Hartmann, H., Bongers, A., Decker, H. (2004). Small-angle X-ray scattering-based three-dimensional reconstruction of the immunogen KLH1 reveals different oxygen-dependent conformations. J. Biol. Chem. 279(4):2841-2845.
17. Herscowitz, H. B., Harold, W. W., Stravitzky, B. A. (1972). Immunochemical and immunogenic properties of a purified keyhold limpet haemocyanin. Immunology 22:51-61.
18. Hewitt, J. (2009). Abnormal glycosylation of dystroglycan in human genetic disease. Review. Biochim. Biophys. Acta.
19. Kafi, K., Betting, D. J., Yamada, R. E., Bacica, M., Steward, K. K., Timmerman, J. M. (2009). Maleimide conjugation markedly enhances the immunogenicity of both human and murine idiotype-KLH vaccines. Mol Immunol. 46(3):448-456.
20. Kirkin, A., Dzhandzhugazyan, K., Zeuthen, J. (1998). The immunogenic properties of melanoma-associated antigens recognized by cytotoxic T lymphocytes. Exp. Clin. Immunogen. 15(1):19-32.
21. Kurokawa, T., Wuhrer, M., Lochnit, G., Geyer, H., Markl, J., Geyer, R. (2002). Hemocyanin from the keyhole limpet Megathura crenulata (KLH) carries a novel type of N-glycans with Gal(á1-6)Man-motifs. Eur. J. Biochem. 269:5459-5473.
22. Laemmli U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259):680-685.
23. Lamping, N., Hoess, A., Yu, B., Park, T. C., Kirschning, C.J., Pfeil, D., Reuter, D., Wright, S. D., Herrmann, F., Schumann, R. R. (1996). Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157(10):4648-4656.
24. Lommerse, J. P. M., Thomas-Oates, J. E., Gielens, C., Preaux, G., Kamerling, J. P., Vliegenthart, J. F. G. (1997). Primary structure of 21 novel monoantennary and diantennary N-linked carbohydrate chains from a-hemocyanin of Helix pomatia. Eur. J. Biochem. 249:195-222.
25. Mailliard, R., Son, Y., Redlinger, R., Coates, P., Giermasz, A., Morel, P., Storkus, W., Kalinski, P. (2003). Dendritic cells mediate NK cell help for Th1 and CTL responses: Two-signal requirement for the induction of NK cell helper function. J. Immunol. 171:2366-2373.
26. Masson, P. R., Gwanzura, L. (1990). Reduced lymphocyte responses to mitogens in natural and experimental trichomoniasis. Infect. Immun. 58:3553-3557.
27. Michele, D., Campbell, K. (2003). Dystrophin-glycoprotein complex: Post-translational processing and dystroglycan function. J. Biol. Chem. 278(18):15457-15460.
28. Moltedo, B., Faunes, F., Haussmann, D., De Ioannes, P., De Ioannes, A., Puente, J., Becker, M. (2006). Immunotherapeutic effect of concholepas hemocyanin in the murine bladder cancer model: Evidence for conserved antitumor properties among hemocyanins. J. Urol. 176(6):2690-2695.
29. O'Brien-Simpson, N. M., Ede, N. J., Brown, L. E. (1997). Polymerization of unprotected synthetic peptides: A view toward synthetic peptide vaccines. J. Am. Chem. Soc. 119:1183-1188.
30. Oyelaran, O., Gildersleeve, J. (2010). Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray. PROTEOMICS Clin. Appl. 4(3):285-294.
31. Pearson, G. R. (1978). In vitro and in vivo investigations on antibody-dependent cellular cytotoxicity. Curr. Topics Microbiol. Immunol. 80:65-96.
32. Pellis, N. R., Shulan, D. J., Kahan, B. D. (1976). Specific tumor immunity induced with soluble materials: Purification of antigens inducing tumor resistance. Biochem. Biophys. Res. Commun. 71:1251-1258.
33. Plitnick, L. M., Herzyk, D. J. (2010). The T-dependent antibody response to keyhole limpet hemocyanin in rodents. Meth. Mol Biol. 598:159-171.
34. Rabinovitch, P. S., June, C. H., Grossmann, A., Ledbetter, J. A. (1986). Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J. Immunol. 137(3):952-961.
35. Salvato, B., Beltramini, M. (1990). Hemocyanins: molecular architecture, structure and reactivity of the binuclear copper active site. Life Chem. Rep. 8:1-47.
36. Sandra, K., Dolashka-Angelova, P., Devreese, B., Van Beeumen, J. (2007). New insights in Rapana venosa hemocyani N-glycosylation resulting from on-line mass spectrometric analyses. Glycobiology 17(2):141-156.
37. Schnurr, M., Galambus, P., Scholz, C., Then, F., Dauer, M., Endres, S., Eigler, A. (2001). Tumor cell lysate pulsed dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for tumor vaccines. Cancer Res. 61:6445-6450.
38. Schumacher, K. (2001). Keyhole limpet hemocyanin (KLH) conjugate vaccines as novel therapeutic tools in malignant disorders. J. Cancer Res. Clin. Oncol. 127(Suppl. 2): R1-R2.
39. Schütz, J., Dolashka-Angelova, P., Abrashev, R., Nicolov, P., Voelter, W. (2001). Isolation and spectroscopic characterization of the structural subunits of keyhole limpet hemocyanin. Biochim. Biophys. Acta 1546:325-336.
40. Teitz-Tennenbaum, S., Li, Q., Davis, M. A., Chang, A. E. (2008). Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model.Clin. Immunol. 129(3):482-491.
41. Terwilliger, N. B. (1998). Functional adaptations of oxygen-transport proteins. J. Exp. Biol. 201:1085-1098.
42. Timmerman, J. M., Levy, R. (2000). Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine. J. Immunol. 164(9):4797-4803.
43. Van Holde K., Miller, K., Decker, H. (2001). Hemocyanins and invertebrate evolution. J. Biol. Chem. 276:15563-15566.
44. Van Kuik, J. A., van Halbeek, H., Kamerling, J. P., Vliegenthart, J. F. (1985). Primary structure of the low-molecular-weight carbohydrate chains of Helix pomatia alphahemocyanin. Xylose as a constituent of N-linked oligosaccharides in an animal glycoprotein. J. Biol. Chem. 260(26):13984-13988.
45. Velkova, L., Todorov, D., Dimitrov, I., Shishkov, S., Van Beeumen. J., Dolashka-Angelova, P. (2009). Rapana venosa hemocyanin with antiviral activity. Biotech. Biotech. Equip. 23(2):606-610.
46. Wandall, H. H., Blixt, O., Tarp, M. A., Pedersen, J. W., Bennett, E. P., Mandel, U., Ragupathi, G., Livingston, P. O., Hollingsworth, M. A., Taylor-Papadimitriou, J., Burchell, J., Clausen, H. (2010). Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res. 70(4):1306-1313.
47. Wirguin, I., Suturkova, M., Milosevic, L., Briani, C., Latov, N. (1995). Keyhole limpet hemocyanin contains Gal(b1-3)-GalNAc determinants that are cross-reactive with the T antigen. Cancer Immunol. 40:307-310.
48. Wuhrer, M., Robijn, M. L. M., Koeleman, C. A. M., Balog, C. I. A., Geyer, R., Deelder, A. M., Hokke, C. H. (2004). A novel Gal(b1-4)Gal(b1-4)Fuc(a1-6)- core modification attached to the proximal N-acetylglucosamine of keyhole limpet hemocyanin (KLH) N-glycans. Biochem. J. 378:625-632.
49. Zhang, S., Graeber, L. A., Helling, F., Ragupathy, G., Adluri, S., Lioyd, K., Livingston, P. (1996). Cancer Res. 56:3315-3319.